Replies to post #127062 on Biotech Values

[DewDiligence]

Are there existing examples where the FDA approved a drug and a patent infringement suit was successful shortly thereafter?

This has happened hundreds of times in cases where the suit was filed by the branded-drug company; what makes the MNTA-Amphastar case unusual is that one generic-drug company is suing another.